This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB01971/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB01971/identifier/chebi/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01971/identifier/kegg-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01971/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01971
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB01971 n13:DB01971
dcterms:title
trans-urocanic acid
adms:identifier
n9:C00785 n10:URO n11:30817 n12:DB01971
n4:synonym
(2E)-3-(1H-imidazol-4-yl)acrylic acid Urocanic acid (E)-3-(1H-imidazol-4-yl)-2-propenoic acid
n4:IUPAC-Name
n5:271B5838-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B583E-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B583D-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B583A-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B583B-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B583C-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B5836-363D-11E5-9242-09173F13E4C5 n5:271B584E-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B5834-363D-11E5-9242-09173F13E4C5 n5:271B5837-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B5835-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B5844-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B5845-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B583F-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B5840-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B5842-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B5841-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B5843-363D-11E5-9242-09173F13E4C5
n4:casRegistryNumber
104-98-3
n4:Bioavailability
n5:271B584A-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B584C-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B584D-363D-11E5-9242-09173F13E4C5
n4:Melting-Point
n5:271B584F-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B5849-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B5848-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B584B-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B5839-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B5846-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B5847-363D-11E5-9242-09173F13E4C5